Tag - ZetrOZ Systems

Clinical Studies Find sam® Developed by ZetrOZ Systems Effectively Treats Osteoarthritis

ZetrOZ Systems, a leading medical device manufacturer and sustained acoustic medicine pipeline development company, announces that a series of studies from 2014 through 2020 found that its sam® (sustained acoustic medicine) technology reduces pain and improves joint function in patients with knee osteoarthritis. In addition, studies show that sam® can cut the overall cost of treatment in half, by $27,000 on average, and reduce lost work time. Read more >>

With Spring Training Around the Corner, ZetrOZ Systems’ sam® Sport is the Ideal Solution for Injury Recovery Without Surgery

Spring training, a baseball tradition nearly old as the game itself, is an exciting time for fans, players and everyone that loves the game. Surfacing after a long winter and an even longer time away from the game due to the pandemic means an increased opportunity for potential injuries. Developed by ZetrOZ Systems, the Sustained Acoustic Medicine (sam®) Wearable Ultrasound has helped athletes at the collegiate level and all the way up to the professional level recover from muscle […]

Sustained Acoustic Medicine Included in Academic and Continuing Education Programs for Healthcare Professionals

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and leader in the development of SAM technology, announces that SAM is a part of academic and continuing education programs for healthcare and medical professionals. Read more >>

SAM 2.0 Treatment Provides Non-Surgical Pain Relief for Federal Employees and Veterans Suffering From Knee Arthritis

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and leader in the development of SAM technology, announces that federal employees on government insurance, including veterans, law enforcement, and first responders, can get access to non-surgical SAM treatment. Read more >>

ZetrOZ Systems Announces Expansion of Sustained Acoustic Medicine (SAM) Continuing Medical Education Courses

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and global leader in the development of SAM technology, announces the expansion of the nationally recognized continuing medical education program, designed to train, and certify professionals including nurses, athletic trainers, physicians and physical therapists on the use and application of SAM technology. Courses will be led through a SAM Learning Management System virtually by Dr. Rod Walters and Dr. Rajiv Mallipudi, who […]

ZetrOZ Systems’ Wearable Ultrasound Device, SAM, Receives Expanded FDA Re-Approval, Positioning the Company for Market Growth in 2021

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the global leader in development of SAM technologies. With its reapproval for expanded use in 2020, the use of SAM ultrasound technology in both professional and at-home applications is expected to increase market growth significantly over the next several years. Read more >>

New Research Study Shows Efficacy of Sustained Acoustic Medicine as Add-on Therapy in Treating Sport-Related Injuries and Returning Athletes to Play

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, was recently evaluated in a research study published in the Global Journal of Orthopedics Research, which measured the effectiveness of SAM treatment to reduce pain and improve function in athletes in conjunction with traditional therapies following sports-related musculoskeletal injuries. Read more >>